Your browser doesn't support javascript.
loading
A single cell RNAseq benchmark experiment embedding "controlled" cancer heterogeneity.
Arigoni, Maddalena; Ratto, Maria Luisa; Riccardo, Federica; Balmas, Elisa; Calogero, Lorenzo; Cordero, Francesca; Beccuti, Marco; Calogero, Raffaele A; Alessandri, Luca.
Afiliação
  • Arigoni M; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Ratto ML; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Riccardo F; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Balmas E; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Calogero L; Department of Electronics and Telecommunications (DET), Politecnico di Torino, Torino, Italy.
  • Cordero F; Department of Computer Science, University of Torino, Torino, Italy.
  • Beccuti M; Department of Computer Science, University of Torino, Torino, Italy.
  • Calogero RA; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy. raffaele.calogero@unito.it.
  • Alessandri L; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Sci Data ; 11(1): 159, 2024 Feb 02.
Article em En | MEDLINE | ID: mdl-38307867
ABSTRACT
Single-cell RNA sequencing (scRNA-seq) has emerged as a vital tool in tumour research, enabling the exploration of molecular complexities at the individual cell level. It offers new technical possibilities for advancing tumour research with the potential to yield significant breakthroughs. However, deciphering meaningful insights from scRNA-seq data poses challenges, particularly in cell annotation and tumour subpopulation identification. Efficient algorithms are therefore needed to unravel the intricate biological processes of cancer. To address these challenges, benchmarking datasets are essential to validate bioinformatics methodologies for analysing single-cell omics in oncology. Here, we present a 10XGenomics scRNA-seq experiment, providing a controlled heterogeneous environment using lung cancer cell lines characterised by the expression of seven different driver genes (EGFR, ALK, MET, ERBB2, KRAS, BRAF, ROS1), leading to partially overlapping functional pathways. Our dataset provides a comprehensive framework for the development and validation of methodologies for analysing cancer heterogeneity by means of scRNA-seq.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benchmarking / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Sci Data Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benchmarking / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Sci Data Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália